Literature DB >> 25269544

Toxicity evaluation of prolonged convection-enhanced delivery of small-molecule kinase inhibitors in naïve rat brainstem.

Sharon L Ho1, Ranjodh Singh, Zhiping Zhou, Ehud Lavi, Mark M Souweidane.   

Abstract

PURPOSE: Convection-enhanced delivery (CED), a local drug delivery technique, is typically performed as a single session and drug concentrations therefore decline quickly post CED. Prolonged CED (pCED) overcomes this problem by performing a long-term infusion to maintain effective drug concentrations for an extended period. The purpose of the current study was to assess the toxicity of using pCED to deliver single and multi-drug therapy in naïve rat brainstem.
METHODS: Sixteen rats underwent pCED of three small-molecule kinase inhibitors in the pons. Single and multi-drug combinations were delivered continuously for 7 days using ALZET mini-osmotic pumps (model 2001, rate of 1 μl/h). Rats were monitored daily for neurological signs of toxicity. Rats were sacrificed 10 days post completion of infusion, and appropriate tissue sections were analyzed for histological signs of toxicity.
RESULTS: Two rats exhibited signs of neurological deficits, which corresponded with diffuse inflammation, necrosis, and parenchymal damage on histological analysis. The remaining rats showed no neurological or histological signs of toxicity.
CONCLUSION: The neurological deficits in the two rats were likely due to injury from physical force, such as cannula movement post insertion and subsequent encephalitis. The remaining rats showed no toxicity and therefore brainstem targeting using pCED to infuse single and multi-drug therapy was well tolerated in these rats.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25269544     DOI: 10.1007/s00381-014-2568-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  20 in total

Review 1.  The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery.

Authors:  D R Groothuis
Journal:  Neuro Oncol       Date:  2000-01       Impact factor: 12.300

2.  Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma.

Authors:  Barbara S Paugh; Alberto Broniscer; Chunxu Qu; Claudia P Miller; Junyuan Zhang; Ruth G Tatevossian; James M Olson; J Russell Geyer; Susan N Chi; Nasjla Saba da Silva; Arzu Onar-Thomas; Justin N Baker; Amar Gajjar; David W Ellison; Suzanne J Baker
Journal:  J Clin Oncol       Date:  2011-09-19       Impact factor: 44.544

Review 3.  Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

Authors:  David J Begley
Journal:  Pharmacol Ther       Date:  2004-10       Impact factor: 12.310

4.  Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump.

Authors:  Adam M Sonabend; R Morgan Stuart; Jonathan Yun; Ted Yanagihara; Hamed Mohajed; Steven Dashnaw; Samuel S Bruce; Truman Brown; Alex Romanov; Manu Sebastian; Fernando Arias-Mendoza; Emilia Bagiella; Peter Canoll; Jeffrey N Bruce
Journal:  Neuro Oncol       Date:  2011-07-12       Impact factor: 12.300

5.  A phase I trial of continuously infused intratumoral bleomycin for the treatment of recurrent glioblastoma multiforme.

Authors:  Roy A Patchell; William F Regine; Paul Ashton; Phillip A Tibbs; Diane Wilson; Diana Shappley; Byron Young
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

6.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

7.  Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.

Authors:  Richard C E Anderson; Benjamin Kennedy; Candix L Yanes; James Garvin; Michael Needle; Peter Canoll; Neil A Feldstein; Jeffrey N Bruce
Journal:  J Neurosurg Pediatr       Date:  2012-12-14       Impact factor: 2.375

Review 8.  Diffuse brainstem glioma in children: critical review of clinical trials.

Authors:  Darren Hargrave; Ute Bartels; Eric Bouffet
Journal:  Lancet Oncol       Date:  2006-03       Impact factor: 41.316

9.  Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers.

Authors:  R A Kroll; M A Pagel; L L Muldoon; S Roman-Goldstein; S A Fiamengo; E A Neuwelt
Journal:  Neurosurgery       Date:  1998-10       Impact factor: 4.654

10.  Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas.

Authors:  Stephanie Puget; Cathy Philippe; Dorine A Bax; Bastien Job; Pascale Varlet; Marie-Pierre Junier; Felipe Andreiuolo; Dina Carvalho; Ricardo Reis; Lea Guerrini-Rousseau; Thomas Roujeau; Philippe Dessen; Catherine Richon; Vladimir Lazar; Gwenael Le Teuff; Christian Sainte-Rose; Birgit Geoerger; Gilles Vassal; Chris Jones; Jacques Grill
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

View more
  2 in total

1.  ABC Transporter Inhibition Plus Dexamethasone Enhances the Efficacy of Convection Enhanced Delivery in H3.3K27M Mutant Diffuse Intrinsic Pontine Glioma.

Authors:  Vadim Tsvankin; Rintaro Hashizume; Hiroaki Katagi; James E Herndon; Christopher Lascola; Talaignair N Venkatraman; Daniel Picard; Brainard Burrus; Oren J Becher; Eric M Thompson
Journal:  Neurosurgery       Date:  2020-05-01       Impact factor: 4.654

2.  Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment.

Authors:  Zhiping Zhou; Ranjodh Singh; Mark M Souweidane
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.